Press Releases

10.28.2011

Pfizer Completes Acquisition Of Icagen

10.14.2011

Findings from DiaGenic, Pfizer R&D Collaboration Show Promising Early Results for Blood-based Test for Early Alzheimer Disease

10.12.2011

deCODE Announces Agreement with Pfizer to Search for Variants in the Human Genome that Confer Risk of Systemic Lupus Erythematosis

10.10.2011

Exonhit enters into Research Agreement with Pfizer to identify Alzheimer’s disease biomarkers

10.05.2011

Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc. For The Development And Commercialization Of Neratinib, An Investigational Pan-HER Inhibitor

10.05.2011

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

10.03.2011

Medimmune'in(Licenses'cancer'immunotherapy'tremelimumab'from'pfizer

09.28.2011

International Structural Genomics Consortium Announces $48.9 MILLION in Additional Funding to Continue the Search for New Medicines

09.09.2011

Lpath Initiates Dosing of iSONEP in First of Two Proof-ofConcept Trials

08.29.2011

Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components

08.16.2011

QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials for lung Cancer

08.03.2011

Biotica regains worldwide rights to its rapamycin analogue program